Fund HoldingsCAXTON CORP

Total Portfolio Value
$19.73M
Total Bought
$494.0K
Total Sold
$42.3K
Net Transaction
+$451.7K
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
REZOLUTE INC1,318,9671,318,96703,3635,67228.74%+2,308
XERIS BIOPHARMA HOLDINGS INC5,113,3485,113,348011,30011,50558.31%+205
LEXEO THERAPEUTICS INC10,31917,851+7,5321622861.45%+125
SPDR S&P 500 ETF TR(SPY)1,8561,869+139711,0175.15%+46
CONTEXT THERAPEUTICS INC018,403+18,4030370.19%+37
BERKSHIRE HATHAWAY INC DEL1,0191,025+64284172.11%-11
ADICET BIO INC17,48817,488041210.11%-20
ABIVAX SA(ABVX)15,80813,900-1,9082261840.93%-42
COMPASS THERAPEUTICS INC43,46543,465086430.22%-43
MIND MEDICINE INC29,06530,383+1,3182732191.11%-54
MOLECULAR TEMPLATES INC136,866136,86603071570.80%-149
KYVERNA THERAPEUTICS INC15,84622,981+7,1353941720.87%-221
Page 1 of 1